Skip to search formSkip to main contentSkip to account menu

Recurrent Digestive System Carcinoma

Known as: Recurrent Gastrointestinal System Cancer, Recurrent Gastrointestinal System Carcinoma 
The reemergence of carcinoma in any part of the digestive system after a period of remission.
National Institutes of Health

Related topics

Related topics

7 relations
Epithelial CellsEpitheliumGastrointestinal systemMalignant Epithelial Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Dynamic monitoring of serum soluble programmed cell death ligand 1 as a response predictor to chemotherapy in metastatic or recurrent gastrointestinal cancer
Background Biomarkers in serum may have important clinical implications for personalized medicine, including therapeutic guidance… 
2014
2014
[Value of the palliative prognostic index, controlling nutritional status, and prognostic nutritional index for objective evaluation during transition from chemotherapy to palliative care in cases of…
OBJECTIVE We investigated whether objective evaluation by using the palliative prognostic index(PPI), controlling nutritional… 
2010
2010
[Oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer patients].
The aim of this study was to introduce an oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer… 
2004
2004
A phase I study of immunotherapy with tumor cell-dendritic cell fusion vaccine in patients with advanced or recurrent gastrointestinal cancer
2615 Background: Immunotherapy with tumor cell-dendritic cell fusion vaccine has been shown to induce the immune response against… 
2004
2004
A phase I study of immunotherapy with tumor cell-dendritic cell fusion vaccine in patients with advanced or recurrent gastrointestinal cancer.
2615 Background: Immunotherapy with tumor cell-dendritic cell fusion vaccine has been shown to induce the immune response against… 
1999
1999
[Biochemical modulation of 5-FU--effect of low dose CDDP].
A pilot study of continuous or intermittent low dose 5-FU and cisplatin chemotherapy (low-dose FP therapy) was conducted at the… 
1994
1994
Radioimmunodetection of cancer of gastrointestinal tract and liver metastasis with I-131 anti-CEA and I-131 anti-CA19-9 monoclonal antibody cocktail (IMACIS-1)
We evaluated the intravenous infusion of a cocktail of I-131 anti-CEA and anti-C A19-9 monoclonal antibody F(ab’)2 (IMACIS-1) in… 
1990
1990
[Early phase II study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90…
Early phase II study in patients with advanced and recurrent gastrointestinal cancer was conducted from August 1986 through… 
1985
1985
[Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
A phase II study on MCNU (Methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside) was performed in 33… 
1983
1983
[Treatment of recurrent gastrointestinal cancer].
There are various patterns of recurrence of gastric and colorectal cancer after radical resection. In case of residual stomach… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)